Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Targeting mTOR to overcome epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer cells. [electronic resource] by
- Fei, Shi-Jiang
- Zhang, Xu-Chao
- Dong, Song
- Cheng, Hua
- Zhang, Yi-Fang
- Huang, Ling
- Zhou, Hai-Yu
- Xie, Zhi
- Chen, Zhi-Hong
- Wu, Yi-Long
Producer: 20140219
In:
PloS one vol. 8
Availability: No items available.
|
|
9.
|
In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines. [electronic resource] by
- Cheng, Hua
- An, She-Juan
- Zhang, Xu-Chao
- Dong, Song
- Zhang, Yi-Fang
- Chen, Zhi-Hong
- Chen, Hua-Jun
- Guo, Ai-Lin
- Lin, Qiu-Xiong
- Wu, Yi-Long
Producer: 20110411
In:
Cancer chemotherapy and pharmacology vol. 67
Availability: No items available.
|
|
10.
|
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals. [electronic resource] by
- Zhu, Jian-quan
- Zhong, Wen-zhao
- Zhang, Guo-chun
- Li, Rong
- Zhang, Xu-chao
- Guo, Ai-lin
- Zhang, Yi-fang
- An, She-juan
- Mok, Tony S
- Wu, Yi-long
Producer: 20080731
In:
Cancer letters vol. 265
Availability: No items available.
|
|
11.
|
Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines. [electronic resource] by
- Xu, Fang-Ping
- Wang, Kun
- Xu, Jie
- Chen, Jie
- Zhang, Yi-Fang
- Wu, Hong-Mei
- Zhang, Ming-Hui
- Long, Xiao-Xu
- Luo, Xin-Lan
- Zhang, Ke-Ping
- Lin, Dan-Yi
- Liu, Yan-Hui
Producer: 20180709
In:
Breast cancer research and treatment vol. 166
Availability: No items available.
|